DeepMed Research

UNIVERSITY OF CALIFORNIA, IRVINE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1965-01-01

Employees: 10K

Market Cap: -

Website: http://www.uci.edu

Clinical Trials

De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx

Recruiting

Conditions: HPV Positive Oropharyngeal Squamous Cell Carcinoma

Interventions: Radiation: Intensity-Modulated Radiation Therapy (IMRT)

First Posted Date: 2022-11-01

Last Posted Date: 2025-02-25

Lead Sponsor: University of California, Irvine

Target Recruit Count: 111

Registration Number: NCT05600842

Locations: 🇺🇸
Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California, United States

Decolonization to Reduce After-Surgery Events of Surgical Site Infection

Phase 4

Recruiting

Conditions: Surgical Site Infection

Interventions: Drug: Soap Without Antiseptic Properties (Placebo)
Drug: 4% Chlorhexidine Gluconate
Drug: 2% Mupirocin
Drug: Placebo Nasal Ointment

First Posted Date: 2022-10-19

Last Posted Date: 2024-08-26

Lead Sponsor: University of California, Irvine

Target Recruit Count: 2700

Registration Number: NCT05586776

Locations: 🇺🇸
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
🇺🇸
University of California, San Francisco Medical Center, San Francisco, California, United States
🇺🇸
University of California, Irvine Medical Center, Orange, California, United States

and more 1 locations

Treatment of Meniere's Disease With Migraine Medications

Phase 4

Recruiting

Conditions: Ménière

Interventions: Drug: nortriptyline + topiramate

First Posted Date: 2022-10-17

Last Posted Date: 2024-08-09

Lead Sponsor: University of California, Irvine

Target Recruit Count: 100

Registration Number: NCT05582837

Locations: 🇺🇸
University of California, Irvine Medical Center ENT Clinic (Pavilion 2), Orange, California, United States

The Heart of the Community Study

Not Applicable

Completed

Conditions: Heart Rate Variability

Interventions: Behavioral: Relational Savoring Intervention

First Posted Date: 2022-09-30

Last Posted Date: 2025-01-15

Lead Sponsor: University of California, Irvine

Target Recruit Count: 84

Registration Number: NCT05560893

Locations: 🇺🇸
Latino Health Access, Santa Ana, California, United States

Youth Nominated Support Team

Not Applicable

Recruiting

Conditions: Psychosis
Family Members
Suicide
Health Care Utilization

Interventions: Behavioral: Youth-Nominated Support Teams for CHR

First Posted Date: 2022-09-28

Last Posted Date: 2025-04-08

Lead Sponsor: University of California, Irvine

Target Recruit Count: 70

Registration Number: NCT05558332

Locations: 🇺🇸
The PREVENT Lab, University of California, Irvine, Irvine, California, United States

A Novel Method for Treating Lung Met w/Combo of Electric Fields & Rad Therapy: A Single-Arm

Early Phase 1

Completed

Conditions: Lung Tumor
Metastatic Cancer

Interventions: Procedure: Irreversible electroporation (IRE) ablation
Radiation: Radiation Therapy

First Posted Date: 2022-09-26

Last Posted Date: 2025-05-14

Lead Sponsor: University of California, Irvine

Target Recruit Count: 6

Registration Number: NCT05555342

Locations: 🇺🇸
Chao Family Comprehensive Cancer Center University of California, Irvine, Orange, California, United States

Acupuncture Therapy and Hypertension

Not Applicable

Recruiting

Conditions: Mild to Moderate Hypertension

Interventions: Other: electroacupuncture

First Posted Date: 2022-09-07

Last Posted Date: 2025-04-15

Lead Sponsor: University of California, Irvine

Target Recruit Count: 120

Registration Number: NCT05530512

Locations: 🇺🇸
Susan Samueli Integrative Health Institute, Irvine, California, United States
🇺🇸
University of California, Irvine, Health Sciences Medical Center, Orange, California, United States

Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer

Phase 2

Recruiting

Conditions: Metastatic Breast Cancer
Hormone Receptor-positive Breast Cancer
Breast Cancer
HER2-negative Breast Cancer

Interventions: Drug: Fulvestrant
Drug: Anastrozole
Drug: Abemaciclib

First Posted Date: 2022-09-01

Last Posted Date: 2024-06-07

Lead Sponsor: University of California, Irvine

Target Recruit Count: 20

Registration Number: NCT05524584

Locations: 🇺🇸
Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, California, United States

Plant-Focused Nutrition in Patients With Diabetes and Chronic Kidney Disease

Not Applicable

Conditions: CKD Stage 4
Chronic Kidney Disease (CKD) With Diabetes Mellitus (DM)
Diabetic Kidney Disease
CKD Stage 3
CKD Stage 5
Diabetes Mellitus

Interventions: Dietary Supplement: PLAFOND diet

First Posted Date: 2022-08-24

Last Posted Date: 2024-07-03

Lead Sponsor: University of California, Irvine

Target Recruit Count: 120

Registration Number: NCT05514184

Locations: 🇺🇸
Harbor-UCLA/Lundquist, Torrance, California, United States
🇺🇸
UCI, Orange, California, United States

Continuous Glucose Monitoring in Dialysis Patients to Overcome Dysglycemia Trial

Not Applicable

Recruiting

Conditions: Diabete Mellitus
Continuous Glucose Monitoring
Hemodialysis

Interventions: Device: Continuous glucose monitoring (CGM)
Device: Usual care (Self-monitored blood glucose)

First Posted Date: 2022-08-22

Last Posted Date: 2024-02-28

Lead Sponsor: University of California, Irvine

Target Recruit Count: 122

Registration Number: NCT05509881

Locations: 🇺🇸
University of California, Irvine, Orange, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy